Literature DB >> 22298367

mTOR/p70S6K in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Giulio Rossi, Alberto Cavazza, Paolo Graziano, Mauro Papotti.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22298367     DOI： 10.1164/ajrccm.185.3.341

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Authors:  Hanako Oba; Kazunori Nishida; Shingo Takeuchi; Hirohiko Akiyama; Koji Muramatsu; Masafumi Kurosumi; Toru Kameya
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

Review 2.  Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience.

Authors:  Zin W Myint; James McCormick; Aman Chauhan; Elizabeth Behrens; Lowell B Anthony
Journal:  Lung       Date:  2018-08-25       Impact factor: 2.584

3.  Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Authors:  Bilal F Samhouri; Natalya Azadeh; Thorvardur R Halfdanarson; Eunhee S Yi; Jay H Ryu
Journal:  ERJ Open Res       Date:  2020-11-16

4.  Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients.

Authors:  Esther López; Alejandro Berna-Erro; Nuria Bermejo; José María Brull; Rocío Martinez; Guadalupe Garcia Pino; Raul Alvarado; Ginés María Salido; Juan Antonio Rosado; Juan José Cubero; Pedro Cosme Redondo
Journal:  J Cell Mol Med       Date:  2013-04-12       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.